Precision therapeutic targets for COVID-19

Precision therapeutic targets for COVID-19

Abstract Beginning in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS-CoV-2 has infected more than 111 million people worldwide and caused over 2.47 million deaths. Individuals infected with SAR...

Full description

Bibliographic Details
Main Authors: Zachary A. Krumm, Grace M. Lloyd, Connor P. Francis, Lith H. Nasif, Duane A. Mitchell, Todd E. Golde, Benoit I. Giasson, Yuxing Xia
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Virology Journal
Subjects:
SARS-CoV-2
COVID-19
MPro
Main protease
RNA-dependent RNA polymerase
Spike protein
Online Access:https://doi.org/10.1186/s12985-021-01526-y

Internet

https://doi.org/10.1186/s12985-021-01526-y

Similar Items